Avita Therapeutics Inc
Fermé
3.94 0.51
Résumé
Variation du prix de l'action
24h
Min
3.82
Max
4.13
Revenu | 1M -11M |
|---|---|
Ventes | 1.6M 19M |
BPA | -0.48 |
Marge bénéficiaire | -55.119 |
Employés | 226 |
EBITDA | 1.1M -8.6M |
Recommandations | Achat Fort |
|---|---|
Prévisions sur 12 Mois | +82.91% upside |
Prochains Résultats | 6 août 2026 |
|---|
Capitalisation Boursière | -14M 121M |
|---|---|
Ouverture précédente | 3.43 |
Clôture précédente | 3.94 |
Avita Therapeutics Inc Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
À Propos Avita Therapeutics Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
